Benzinga | Apr 13, 2021 07:02AM EDT

B of A Securities Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $25

B of A Securities initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Buy rating and announces Price Target of $25.